P. Genissel

发表

Investigation of a cyclopropyl-containing drug by on-line high-performance liquid chromatography/nuclear magnetic resonance

M. Spraul, W. Bermel, K. Albert, 1989 .

Pharmacokinetics of rilmenidine.

P. Zech, N. Pozet, J. Ehrhardt, 1988, The American journal of cardiology.

Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.

M. D. de Broe, G. Verpooten, P. Genissel, 1991, British journal of clinical pharmacology.

Assessment of the sustained release properties of a new oral formulation of trimetazidine in pigs and dogs and confirmation in healthy human volunteers

P. Jaillon, Y. Chodjania, P. Genissel, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug

S. Goldstein, L. Kraus-Berthier, A. Pierré, 2002, Cancer Chemotherapy and Pharmacology.

Improvement in the selectivity and metabolic stability of the serotonin 5-HT1A ligand, S 15535: A series of cis- and trans-2-(arylcycloalkylamine) 1-indanols

M. Millan, A. Newman-Tancredi, J. Péglion, 2002 .

Thepharmacokinetics ofperindopril andits effects onserum angiotensin converting enzymeactivity inhypertensive patients withchronic renal failure

P. Desché, P. Sweny, P. Genissel, 1992 .

The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.

P. Desché, P. Sweny, P. Genissel, 1992, British journal of clinical pharmacology.

Fatty acid binding proteins shape the cellular response to activation of the glucocorticoid receptor

R. Weaver, C. Porter, M. Scanlon, 2021, bioRxiv.

A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor alpha agonists.

R. Weaver, L. Vuillard, C. Porter, 2019 .

A ligand-induced structural change in fatty acid–binding protein 1 is associated with potentiation of peroxisome proliferator–activated receptor α agonists

R. Weaver, L. Vuillard, C. Porter, 2018, The Journal of Biological Chemistry.

Microdialysis probes calibration: gradient and tissue dependent changes in no net flux and reverse dialysis methods.

G. Houin, B. Marchand, P. Genissel, 1995, Journal of pharmacological and toxicological methods.

Microdialysis: an alternative for in vitro and in vivo protein binding studies.

G. Houin, A. Tufenkji, P. Genissel, 1994 .

Pharmacokinetics of rilmenidine in healthy subjects.

J. Fourtillan, P. Genissel, H. Albin, 1988, The American journal of cardiology.

NEUROPHARMACOKINETICS OF A NEW α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC ACID (AMPA) MODULATOR, S18986 [(S)-2,3-DIHYDRO-[3,4]CYCLOPENTANO-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE], IN THE RAT

K. Bernard, J. Scherrmann, F. Bourasset, 2005, Drug Metabolism and Disposition.

Use of hepatocyte cultures for preliminary metabolism and cytotoxicity studies of a new anti-hypertensive agent, oxaminozoline.

A. Guillouzo, P. du Vignaud, P. Genissel, 1988, Xenobiotica; the fate of foreign compounds in biological systems.